Coulter Partners Recruits CFO for iOnctura
September 3, 2025 – Life sciences recruiting specialist Coulter Partners has recruited Steven Sciuto as the new CFO of iOnctura. “Following our successful initiation of a number of Phase II studies for our lead asset, roginolisib, we are committed to building a world-class leadership team that not only delivers on the promise of this asset but also strengthens our entire portfolio,” said Catherine Pickering, CEO and co-founder of iOnctura. “As we enter the next phase of our strategy, every new leader has been carefully chosen for their expertise, vision and ability to drive transformative growth – and Steve joins us to do just that. Together, we will propel the company forward, ensuring we are well-positioned for the next chapter of our journey and sustained success.”
“We were impressed with Coulter Partners‘ seamless execution of this search,” Dr. Pickering said. “Their extensive network in the CFO market ensured a consistent stream of high-caliber candidates, providing us with a diverse pool to choose from. Coulter Partners’ ability to leverage their insights and provide valuable market intelligence on candidate profiles truly supported our decision-making process and ultimately led us to an exceptional fit for iOnctura.”
Mr. Sciuto is a seasoned finance executive with more than 15 years of corporate finance leadership and capital markets experience within the life sciences industry. He has played pivotal roles in scaling financial operations, raising over $400 million through private and public financing, and leading complex transactions. Prior to joining iOnctura, Mr. Sciuto was most recently at Neurogene Inc., where he held various roles of increasing responsibility within the finance organization, culminating as vice president of finance.
“I am excited to join iOnctura at such a pivotal time in its growth,” said Mr. Sciuto. “With a strong foundation already in place, and an unrelenting mission to combat rare and hard-to-treat cancers, I look forward to working with the talented team at iOnctura to drive financial and strategic initiatives, to accelerate development and ensure sustainable success over the coming years.”
iOnctura is a clinical-stage biotechnology company based in Geneva, Switzerland, focused on developing next-generation, oral small-molecule therapies that target the tumor microenvironment to overcome immune resistance in cancer.
Life Sciences Specialists
Coulter Partners is a board- and senior-level global executive search specialist focused exclusively on life sciences. The firm works closely with those at the cutting edge of innovation in the industry to understand their challenges. With an extensive global network and expertise gained over 25 years in the sector, Coulter Partners is a trusted leadership adviser in the pharmaceuticals, biotechnology, medical technology, diagnostics, health-tech, CRO, and services sectors.
Related: Leadership Void: Change Agents Sought for Life Sciences Sector
Coulter Partners also works closely with the global investor community, hiring for their own teams as well as building the boards and executive leadership teams of their portfolio companies. Coulter Partners’ team of 95 completes over 260 assignments a year working from 14 offices across the U.K., EMEA, the U.S., and APAC.
The Select Guide to America’s Top 250 Executive Search Firms
Hunt Scanlon Media proudly presents the Select Guide to America’s Top 250 Executive Search Firms.
This comprehensive online directory is your definitive resource for finding the best executive search firms to serve your talent needs.
Our guide is meticulously curated to connect you with leading firms that specialize in various industries and functions, ensuring you find the perfect match for your executive recruitment needs.
Bianca Coulter founded Coulter Partners in 2003 and has 25 years’ experience of board and C-level global search, building the leadership teams of early-stage, mid-cap, and global multinationals in over 20 countries. Through appointing leadership, Ms. Coulter channels her judgment and expertise to impact patient benefit and assist those at the cutting edge of life science to achieve their goals.
Chief Scientific Officer Search
Coulter Partners recently placed Frederick Westhorpe as chief scientific officer of Biomia. “We are excited to welcome Frederick to Biomia, and confident that his extensive small molecule drug discovery and development expertise will complement the team and guide our company’s next phase of strategic growth,” said Michael Krogh Jensen, Biomia’s co-founder and CEO. “Frederick’s almost decade-long experience in preclinical drug development, and specifically his recognized leadership in progressing CNS small molecule R&D programs to clinical readiness across a variety of CNS indications, will strengthen our capabilities as we advance our pipeline of small molecule therapeutic candidates towards the clinic.”
“We are incredibly pleased with the partnership we’ve had with Coulter Partners throughout this critical search,” he continued. “Their deep understanding of the life sciences landscape and their commitment to finding the perfect fit were instrumental in bringing a leader of Frederick Westhorpe’s caliber to Biomia. This successful placement underscores the value of true collaboration in building a world-class scientific team.”
Related: Mastering Senior-Level Job Interviews in Life Sciences and Healthcare
Contributed by Scott A. Scanlon, Editor-in-Chief and Dale M. Zupsansky, Executive Editor – Hunt Scanlon Media
